http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201722411-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad550e692a922a82e176706c73621bf1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0964f4b2797e921c3f98ccbaab5a85fa |
| publicationDate | 2017-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201722411-A |
| titleOfInvention | Pharmaceutical composition for treating lung cancer |
| abstract | A pharmaceutical composition for treating lung cancer, which is suitable for treating an individual suffering from lung cancer, the pharmaceutical composition comprising: a first agent comprising at least dehydrogenated perforate (DeEA); and a second agent comprising at least Anthraquinone acid K (AnK); and an extract thereof, each of which can be obtained from a fruiting body or mycelium of Antrodia camphorata, wherein the first medicament and the first medicament are compared to the first medicament or the second medicament alone The two agents are used to treat lung cancer, prevent lung cancer metastasis, or reduce the risk of lung cancer metastasis showing a synergistic effect. |
| priorityDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 267.